One drug does not fit every patient.

Flexible dosage forms need flexible material systems

Personalization may require smaller units, adjustable dose combinations, rapid manufacture or dosage forms with unusual geometries and release patterns. Excipients must support the selected manufacturing process while remaining acceptable for the target population.

3D printing changes the excipient question

In pharmaceutical 3D printing, material properties influence printability, layer formation, mechanical strength, disintegration, release and stability. A material that is well understood in conventional tableting may behave very differently in extrusion, powder-bed or ink-based printing.

Commercialization is the harder part

Personalized manufacturing raises questions about scale, quality control, equipment qualification, digital workflow, regulatory responsibility and cost. A clinically attractive concept has to be converted into a reproducible manufacturing and release system.

A practical route forward

The near-term opportunity is likely to combine standardization with flexibility: validated material systems and process windows that can produce a defined range of doses or product configurations. Excipients are central because they connect formulation performance to manufacturing flexibility.